BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Staging
11 results:

  • 1. Is Dissection and Preservation of Adherent Popliteal Vessels From a Posterior Soft Tissue Mass Associated With a Higher Proportion of Local Recurrence in Patients With a Distal Femoral Osteosarcoma?
    Ebeid W; Elghoneimy A; Abousenna W
    Clin Orthop Relat Res; 2023 Nov; 481(11):2167-2176. PubMed ID: 37527334
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma.
    Karg MM; John L; Refaian N; Buettner C; Rottmar T; Sommer J; Bock B; Resheq YJ; Ksander BR; Heindl LM; Mackensen A; Bosch JJ
    Mol Cancer Res; 2022 Aug; 20(8):1320-1336. PubMed ID: 35503453
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The utility of cerebrospinal fluid-derived cell-free DNA in molecular diagnostics for the
    Chen WL; Pao E; Owens J; Glass I; Pritchard C; Shirts BH; Lockwood C; Mirzaa GM
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483878
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.
    Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B
    Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.
    Stachyra K; Dudzisz-Śledź M; Bylina E; Szumera-Ciećkiewicz A; Spałek MJ; Bartnik E; Rutkowski P; Czarnecka AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208339
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Merkel Cell Carcinoma Therapeutic Update.
    Cassler NM; Merrill D; Bichakjian CK; Brownell I
    Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma.
    de Waal AC; van Harten-Gerritsen AS; Aben KK; Kiemeney LA; van Rossum MM; Blokx WA
    Br J Dermatol; 2014 Apr; 170(4):874-7. PubMed ID: 24593233
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
    Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
    Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Effects of vascular endothelial growth factor D on the signaling cascade of sentinel lymphatic endothelial cells from melanoma patients undergoing sentinel lymphadenectomy].
    Kawai Y; Takeda A; Gershenwald JE
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2141-4. PubMed ID: 14712780
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma.
    Wang X; Heller R; VanVoorhis N; Cruse CW; Glass F; Fenske N; Berman C; Leo-Messina J; Rappaport D; Wells K
    Ann Surg; 1994 Dec; 220(6):768-74. PubMed ID: 7986144
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma.
    Kersey PA; Iscoe NA; Gapski JA; Osoba D; From L; DeBoer G; Quirt IC
    Br J Surg; 1985 Aug; 72(8):614-7. PubMed ID: 4027532
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.